Brief: Gland Pharma Receives Approval From USFDA For Norepinephrine Bitartrate In 5% Dextrose Injection
12/08/2025 08:37
Aug 12 (Reuters) - Gland Pharma Ltd GLAD.NS: RECEIVES APPROVAL FROM USFDA FOR NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION Further company coverage: GLAD.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant